<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39438695</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>22</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>The association of increased incidence of congenital heart disease in newborns with maternal COVID-19 infection during pregnancy.</ArticleTitle><Pagination><StartPage>24866</StartPage><MedlinePgn>24866</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">24866</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-76690-6</ELocationID><Abstract><AbstractText>This paper aims to examine the potential link between maternal COVID-19 infection during pregnancy and the increased risk of congenital heart disease (CHD) in newborns. A comparative analysis was conducted involving two groups: mothers infected with COVID-19 during pregnancy and a control group. Data on maternal characteristics, pregnancy-related complications, and newborn outcomes were collected and analyzed. Additionally, the annual incidence rates of CHD from 2020 to 2023 were evaluated to assess trends over time. No significant differences were found between the COVID-19 cases and the control group in terms of maternal age, BMI, gravidity, parity, use of assisted reproductive technology, adverse obstetric history, or complications during pregnancy, including diabetes mellitus, preeclampsia, and thyroid abnormalities. For newborn outcomes, there were no significant differences in sex distribution, rate of cesarean delivery, Apgar scores, or birth weight. However, a significantly higher prevalence of cardiac ultrasound abnormalities was observed in the COVID-19 group (10.08%) compared to the control group (4.13%, p = 0.012). Further analysis revealed that the majority of cardiac abnormalities in the COVID-19 group occurred in mothers infected before 8 weeks of pregnancy. The annual incidence rates of CHD showed a significant increase during the COVID-19 pandemic, with the highest rate in 2023 (5.46%) compared to previous years. Maternal COVID-19 infection during pregnancy may adversely affect the development of the newborn's heart. This could be due to the inflammatory response caused by the viral infection or other pathological processes. The findings underscore the importance of vigilant prenatal care and early detection of cardiac abnormalities during the pandemic and suggest the need for further research to explore potential mechanisms and intervention strategies.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Huimin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Shanxi Province Integrated Traditional and Western Medicine Hospital, Taiyuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xianhui</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Children's Hospital of Shanxi Province, Taiyuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Sufeng</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Shanxi Province Integrated Traditional and Western Medicine Hospital, Taiyuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pathology, Stanford University School of Medicine, Palo Alto, CA, 94305, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Shanxi Provincial People's Hospital, Taiyuan, 030001, China. wangwei860351@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006330" MajorTopicYN="Y">Heart Defects, Congenital</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011251" MajorTopicYN="Y">Pregnancy Complications, Infectious</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011256" MajorTopicYN="N">Pregnancy Outcome</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Congenital heart disease</Keyword><Keyword MajorTopicYN="N">Newborns</Keyword><Keyword MajorTopicYN="N">Pregnancy infection</Keyword><Keyword MajorTopicYN="N">Risk factors</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>7</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>23</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39438695</ArticleId><ArticleId IdType="pmc">PMC11496507</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-76690-6</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-76690-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ivanov, D. Transformation of supply chain resilience research through the COVID-19 pandemic. Int. J. Prod. Res., 1–22, 10.1080/00207543.2024.2334420</Citation></Reference><Reference><Citation>Andrighetto, G. et al. Changes in social norms during the early stages of the COVID-19 pandemic across 43 countries. Nat. Commun.15, 1436. 10.1038/s41467-024-44999-5 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10873354</ArticleId><ArticleId IdType="pubmed">38365869</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, L. et al. Analysis of the pregnancy outcomes in pregnant women with COVID-19 in Hubei Province. Zhonghua Fu Chan Ke Za Zhi.55, 166–171. 10.3760/cma.j.cn112141-20200218-00111 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32145714</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Mascio, D. et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am. J. Obstet. Gynecol. MFM. 2, 100107. 10.1016/j.ajogmf.2020.100107 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7104131</ArticleId><ArticleId IdType="pubmed">32292902</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan, M. S. I. et al. Risk of congenital birth defects during COVID-19 pandemic: draw attention to the physicians and policymakers. J. Glob Health.10, 020378. 10.7189/jogh.10.020378 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7690649</ArticleId><ArticleId IdType="pubmed">33274057</ArticleId></ArticleIdList></Reference><Reference><Citation>Wastnedge, E. A. N. et al. Pregnancy and COVID-19. Physiol. Rev.101, 303–318. 10.1152/physrev.00024.2020 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7686875</ArticleId><ArticleId IdType="pubmed">32969772</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandt, J. S. et al. Epidemiology of coronavirus disease 2019 in pregnancy: risk factors and associations with adverse maternal and neonatal outcomes. Am. J. Obstet. Gynecol.224, 389e381–389e389. 10.1016/j.ajog.2020.09.043 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7518835</ArticleId><ArticleId IdType="pubmed">32986989</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng, L. et al. Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China. JAMA Pediatr.174, 722–725. 10.1001/jamapediatrics.2020.0878 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7099530</ArticleId><ArticleId IdType="pubmed">32215598</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, N. et al. Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study. Lancet Infect. Dis.20, 559–564. 10.1016/s1473-3099(20)30176-6 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7158904</ArticleId><ArticleId IdType="pubmed">32220284</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendoza, M. et al. Pre-eclampsia-like syndrome induced by severe COVID-19: a prospective observational study. Bjog. 127, 1374–1380. 10.1111/1471-0528.16339 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7300912</ArticleId><ArticleId IdType="pubmed">32479682</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelkader, M. A. et al. Congenital heart disease in a patient with COVID-19 infection during early pregnancy: a case report. Egypt. Heart J.74, 61. 10.1186/s43044-022-00295-5 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9419912</ArticleId><ArticleId IdType="pubmed">36030341</ArticleId></ArticleIdList></Reference><Reference><Citation>Korinets, Y. &amp; Prokopchuk, N. Congenital and Hereditary Pathology in Women contracted Covid-19 during pregnancy. Sci. J. Polonia Univ.61, 158–167. 10.23856/6120 (2024).</Citation></Reference><Reference><Citation>Vivanti, A. J. et al. Transplacental transmission of SARS-CoV-2 infection. Nat. Commun.11, 1–7 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7360599</ArticleId><ArticleId IdType="pubmed">32665677</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, M., Chen, L., Zhang, J., Xiong, C. &amp; Li, X. The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study. PLoS One. 15, e0230295. 10.1371/journal.pone.0230295 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7161957</ArticleId><ArticleId IdType="pubmed">32298273</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandibur, T. E. et al. Does COVID-19 Infection during Pregnancy Increase the Appearance of Congenital Gastrointestinal Malformations in Neonates? Biomedicines.11, 3105. 10.3390/biomedicines11123105 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10740856</ArticleId><ArticleId IdType="pubmed">38137326</ArticleId></ArticleIdList></Reference><Reference><Citation>Samples, S., Patel, S., Lee, S., Gotteiner, N. &amp; Patel, A. Incidence of fetal Arrhythmia before and during the COVID-19 pandemic: a single-center experience. Pediatr. Cardiol.10.1007/s00246-024-03439-3 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38413418</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayar, M., Tekin, H. G., Sevinç, Y., Öztekin, D., &amp; Olukman, Ö. Evaluation of neurological and cardiac development of newborn infants born to mothers infected with COVID-19: Does COVID-19 affect the development of newborn infants?. J. Sur. Med. 6 (8), 739–741 (2022).</Citation></Reference><Reference><Citation>Popescu, D. E. et al. How much does SARS-CoV-2 infection during pregnancy affect the neonatal brain, heart, and kidney? A parallel between COVID-19, vaccination, and normal pregnancy. Life. 14, 224. 10.3390/life14020224 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10889919</ArticleId><ArticleId IdType="pubmed">38398733</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckingham, M., Meilhac, S. &amp; Zaffran, S. Building the mammalian heart from two sources of myocardial cells. Nat. Rev. Genet.6, 826–835. 10.1038/nrg1710 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16304598</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan, C. M. J. &amp; Lewandowski, A. J. The Transitional Heart: from early embryonic and fetal development to neonatal life. Fetal Diagn. Ther.47, 373–386. 10.1159/000501906 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7265763</ArticleId><ArticleId IdType="pubmed">31533099</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye, Z. et al. Maternal viral infection and risk of fetal congenital heart diseases: a Meta-analysis of Observational studies. J. Am. Heart Assoc.8, e011264. 10.1161/jaha.118.011264 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6512143</ArticleId><ArticleId IdType="pubmed">30995883</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidarzadeh, M., Taheri, M., Mazaheripour, Z. &amp; Abbasi-Khameneh, F. The incidence of congenital anomalies in newborns before and during the Covid-19 pandemic. Ital. J. Pediatr.48, 174. 10.1186/s13052-022-01368-6 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9479418</ArticleId><ArticleId IdType="pubmed">36109775</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen, S. A., Smulian, J. C., Lednicky, J. A., Wen, T. S. &amp; Jamieson, D. J. Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. Am. J. Obstet. Gynecol.222, 415–426. 10.1016/j.ajog.2020.02.017 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7093856</ArticleId><ArticleId IdType="pubmed">32105680</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman, L. F. et al. Congenital anomalies and predisposition to severe COVID-19 among pediatric patients in the United States. Pediatr. Res.10.1038/s41390-024-03076-9 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38365873</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>